Navigation Links
Zometa [Novartis Drug] For Treatment Of Paget’s Diseas

Results of the clinical study carried out by Professor Ian Reed and his team from the University of Auckland in New Zealand has found that the drug Zometa manufactured by Novartis treats Paget’s disease// far better than the drug Actonel produced by Procter and Gamble.

Paget's disease is a condition in which the bones breaks or becomes weak faster than the normal and the new bone replacement does not replace it properly. Paget’s disease occurs in about 2 percent of people above the age of 60. In serious conditions Paget’s disease can be very painful and can lead to bone fractures.

Zometa [Novartis drug], halted bone deterioration and abnormal bone growth for at least a year in about 95 percent of patients with Paget's disease. Dr. Paul Miller, collaborator of test centers at 75 medical centers in 10 countries said, "Zometa produced a "higher response, faster response and a longer duration of remission" in tests against daily treatments of Procter & Gamble Pharmaceutical's Actonel”. The results of the study which was published in The New England Journal of Medicine found that Zometa led to six months of improvement in 96 percent of 176 people tested.

Though, the drug Zometa can produce mild side effects, flu-like symptoms such as mild fever and muscle aches these symptoms disappear after four days, said the researchers, led by Ian Reed of the University of Auckland in New Zealand. Zoledronic acid is approved by Food and Drug Administration as a treatment for Paget's disease in Canada and 27 European countries and the drug is under review by the U.S
'"/>




Page: 1

Related medicine news :

1. Novartis files application with FDA for Zometa
2. Advances in Treatment of Cataracts
3. Recommendations for Treatment of Blood Pressue
4. Treatment for Menieres disease
5. Treatment for pre-menstrual syndrome is ineffective
6. Better Treatment for obesity
7. Gene Treatment for Heart Disease
8. More People Seeking Treatment for Depression
9. Focused Treatment For Childhood Cancer
10. Inadequate Drug Treatment For Youth
11. FDA Approves New surgery Treatment for Farsightedness
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is ... a fitness app. The fitness app plans to fix the two major problems leading the ... one size fits all type program , They don’t eliminate all the reasons ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... NORTHBROOK, Ill. and BOGOTA, Colombia , June 23, 2016  Astellas today announced the ... joins Astellas Farma Brasil as the company,s second affiliate in Latin America . ... ... appointed General Manager of Astellas Farma Colombia ... ...
(Date:6/23/2016)... , June 23, 2016  Guerbet announced today ... Inc.,s Supplier Horizon Award . One ... Guerbet was recognized for its support of Premier members ... through clinical excellence, and commitment to lower costs. ... receive this recognition of our outstanding customer service from ...
(Date:6/23/2016)... Research and Markets has announced ... Analysis (United States, China, Japan, Brazil, United Kingdom, Germany, ... offering. Surgical Procedure ... planners, provides surgical procedure volume data in a geographic ... in-depth analysis of growth drivers and inhibitors, including world ...
Breaking Medicine Technology: